Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a clinical-stage biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), a liver disease with high unmet medical need. Madrigal’s lead candidate, resmetirom, is a once daily, oral, thyroid hormone receptor (THR)...
Use this information to figure out if this company is an ideal customer for you.
(267) 513-xxxx
Madrigal Pharmaceuticals's CEO is Bill Sibold
Madrigal Pharmaceuticals's CMO is Rebecca Taub
Madrigal Pharmaceuticals's CFO is Alex Howarth
Madrigal Pharmaceuticals's phone number is (267) 513-xxxx
Madrigal Pharmaceuticals's official website is madrigalpharma.com
Madrigal Pharmaceuticals's revenue is $50M - $100M
Madrigal Pharmaceuticals has 11 - 50 employees
Madrigal Pharmaceuticals is in the industry of: Pharmaceuticals